Molecular Pharmacology completes cancellation of 20 million shares

By Elaine Rigoli

Tampa, Fla., July 21 - Molecular Pharmacology (USA), Ltd. on Friday reported the return and cancellation of 20 million shares of the common stock of Molecular to treasury.

These shares were returned to the company by Byron Cox, a former director and Molecular officer.

As of Friday, Molecular has 111,553,740 shares issued and outstanding on a fully diluted basis.

Molecular is a public biotechnology company based in Los Angeles.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.